Biologicals
More yield means more residue, and elevated diesel prices equal a costly fall. Mosaic Biosciences’ new enzyme digester costs about $10 an acre. Application timing decides whether that money buys field operations, emergence/final stand or nutrients.
Private labels are proving to be one way businesses are forging a new path.
Backed by Leaps by Bayer, Robigo says its engineered microbes matched chemical-level control of Sudden Death Syndrome in soybeans in year-one trials, while delivering a 3x yield gain against fusarium wilt in lettuce and berries — with commercial launches targeted for 2028 and 2029.
Sound Agriculture adds seed treatment to its product portfolio, with nutrient use efficiency in focus.
Crop protection, seeds and digital tools could be rolled into a standalone company by middle of next year.
Andre Cerignoni will oversee both BioWorks and BIOTROP’s row-crop business, which remain separate brands under a shared platform.
The biologicals market is growing quickly—and with that growth comes a flood of competing claims, products, and information.
The announcement was made during Meristem’s annual Breakthrough to Excellence event for Meristem dealer partners from across the country.
Biological Crop Inputs Expand U.S. Distribution Through Wilbur-Ellis, REDSTAR and Rovensa Next Deals
A trio of distribution deals involving Wilbur-Ellis, REDSTAR and Rovensa Next signals continued momentum for biological crop inputs — and a sharper focus on moving products through established retail and agronomic service networks.
New Stratus data shows grower satisfaction and use are rising, but the category’s future may depend on realistic expectations, agronomic positioning and proof close to the farm.
How one farmer’s soil health success funded a community-focused business.
Industry experts project biological crop protection solutions will achieve complete market parity with conventional synthetic pesticides by 2040.
These tools aim to help retailers manage their time, provide accuracy in recommendations and reduce risk in agronomic decisions.
Huma expands Surf-Max access to California as western water pressures intensify
Now present in seven states, the small pest is taking a toll on soybean crops and making Midwest growers look beyond traditional insecticides for yield protection.
With one survey showing 48% of Midwest corn and soybean growers are unable to afford traditional fertilizer sources, Extension and industry are responding with nutrient options that can lend support.
Temple Rhodes explains how moving away from front-loaded fertilizer use to what he calls a “layered, systematic approach” — using nitrogen, phosphorus and biologicals — is helping him build corn yields despite increased regulatory demands.
University of Illinois researcher details scenarios in corn and soybeans where biological products can provide value.
PI AgSciences aims to bring to market a new mode of action in row crops and specialty crops.
First launched in 2024, TS201 was registered as a corn bioinsecticide to repel corn rootworm larvae.
Before the 2025 growing season, Kevin Kalb had tried more than 30 biological products. And he had all but written off the entire product category.
Adding Low Mu Tech to the company illustrates the company’s ambition toward vertical integration across crop nutrition, biologicals, and data analytics.
Planning for next season? Review the expert insights and recommendations from farmers and field agronomists on how to reduce costs and strategically reallocate resources.
“It also allows Growmark to influence another critical point in the ag value chain to better serve its members and customers,” said Growmark Executive Vice President and Chief Operating Officer Brad Drake.
“This acquisition will bring scale and even more relevancy in distribution because we’ll be coming in with a bigger portfolio,” says Mike Steffeck, CEO of HGS BioScience.
The three companies will unify as Sumitomo Biorational Company starting in April 2026
When complete, the facility will produce 66,000 gallons of product every month.
The biological company expands its R&D headquarters and has a lineup of products launches ready for the field, pending regulatory approval.